Accelerating Severe ME/CFS Research
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes
August 6, 2026
August is Severe ME/CFS Awareness Month–a time to reflect on the toll this disease takes
This quarter’s summaries highlight several studies examining the biological mechanisms of ME/CFS and Long Covid,
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit
Solve M.E. today announced Renegade Research as the latest recipient of our ME/CFS Catalyst Award,
Our CEO, Emily Taylor, is featured in LA Weekly for her leadership in shaping the
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
When an organization, like a government agency, company, or nonprofit, considers a big change or
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
Dear Friends, As this year comes to a close, I find myself thinking not just